GPD2 and thyroid gland carcinoma: mGPDH silencing reduces the sensitivity of metformin to inhibit mitochondrial oxidative phosphorylation (OXPHOS) and growth, whereas mGPDH overexpression sensitizes thyroid cancer cells to the growth inhibitory effects of mitochondrial respiration and metformin.